Enliven Therapeutics
ELVN
#5218
Rank
S$1.57 B
Marketcap
$33.27
Share price
5.84%
Change (1 day)
78.01%
Change (1 year)

Enliven Therapeutics (ELVN) Fails to deliver data

Key failure to deliver metrics for Enliven Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Enliven Therapeutics (ELVN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Enliven Therapeutics (ELVN) - since 2023

Volume in USD (price x number of shares), data since 2023

Enliven Therapeutics (ELVN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$7.17 M-60.94%
2023S$18.36 M